lying cause of death reported on death certificates filed in all 50 states and the District of Columbia reflecting more than 99% of deaths. Deaths were identified by International Classification of Diseases, , codes 153, 154, and 159 during 1970 153, 154, and 159 during -1998 153, 154, and 159 during and ICD-10 codes C18 to C20 and C26 during 1999 153, 154, and 159 during -2014 . Rates were stratified by race (black, white, and other) and age (20-29, 30-39, 40-49, and 50-54 years) . Trends were quantified using the Joinpoint Regression Program (National Cancer Institute), version 4.4.0.0, which uses permutation analysis to fit a series of straight lines on a logarithmic scale to observed rates to estimate annual percent change (APC), resulting in trends of variable length. Trends were only described as increasing or decreasing when the APC was significantly different from 0 (P < .05) using a 2-sided test.
Results | During 1970-2014, 242 637 people aged 20 to 54 years died from CRC at a median age of 49 years (interquartile range, 44-52). Decedents were 54% male, 80% white, 17% black, and 3% other race. CRC mortality rates per 100 000 population among individuals aged 20 to 54 years declined from 6.3 in 1970 to 3.9 in 2004, then increased by 1.0% annually (95% CI, 0.7% to 1.4%) to 4.3 in 2014 (Figure) . The increase was confined to white individuals, among whom mortality rates increased by 1.4% annually (95% CI, 1.1% to 1.8%), from 3.6 in 2004 to 4.1 in 2014. Among black individuals, mortality rates declined by 0.4% annually (95% CI, −0.6% to −0.3%) to 1.1% annually (95% CI, −1.5% to −0.7%), from 8.1 in 1970 to 6.1 in 2014. Among other races combined, mortality rates declined from 1970-2006 and were stable thereafter.
In age-stratified analyses, mortality trends in white individuals during the most recent period defined by joinpoint were stable for those aged 20 to 29 years from 1988-2014, but increased by 1.6% annually (95% CI, 1.2% to 2.1%) for those aged 30 to 39 years from 1995-2014, by 1.9% annually (95% CI, 1.2% to 2.5%) for those aged 40 to 49 years, and by 0.9% annually (95% CI, 0.1% to 1.6%) for those aged 50 to 54 years from [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] (Table) . In contrast, rates in black individuals decreased over the entire study period among those aged 20 to 49 and since 1993 among those aged 50 to 54 years.
Discussion | CRC mortality rates decreased since 1970 in black individuals aged 20 to 54 years, but increased in white individuals since 1995 among those aged 30 to 39 years and since 2005 among those aged 40 to 54 years following decades of decline. These trends are consistent with CRC incidence from 1998-2009 among those younger than 50 years, which was stable in black individuals, but increased in white individuals by 1.5% annually for local-stage and regional-stage disease and by 3% annually for distant-stage disease.
2 Disparate racial patterns conflict with trends in major CRC risk factors like obesity, which are similar in white and black individuals.
5
Although 5-year survival in persons aged 15 to 64 years has improved, 3 mortality is a function of incidence and survival and can increase if increased CRC occurrence is of sufficient magnitude to outweigh improvements in survival. 3 Increased mortality is particularly unexpected among those aged , 5 line segments) that vary in length to reflect differences in the pattern of observed rates. c Indicates the APC is statistically significantly different from 0 (P < .05) using a 2-sided test based on the permutation method.
